Maximizing value and minimizing waste in clinical trial research in swine: Design features to minimize bias
Journal of Swine Health and Production · 01.03.2023 · 31 (2) · 82-86
DOI: 10.54846/jshap/1313 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Swine Health and Production, online erschienen am 01.03.2023. Verfasst von Jan Sargeant und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Researchers designing trials should implement design features intended to reduce bias. These include random allocation to intervention groups and blinding of caregivers and outcome assessors. The method of generating the random sequence should be reported, as well as methods for stratification or blocking if used. When blinding is not possible, objectively measured outcomes should be used. Allocation concealment may not be essential when all eligible pens or animals are enrolled and there is no preference for intervention group. An a priori trial protocol should be made publicly available, and results for all outcomes evaluated should be reported.
Zitieren
APA
Sargeant, J., O'Connor, A., O'Sullivan, T., & Ramirez, A. (2023). Maximizing value and minimizing waste in clinical trial research in swine: Design features to minimize bias. Journal of Swine Health and Production, 31(2), 82-86. https://doi.org/10.54846/jshap/1313
Vancouver
Sargeant J, O'Connor A, O'Sullivan T, Ramirez A. Maximizing value and minimizing waste in clinical trial research in swine: Design features to minimize bias. Journal of Swine Health and Production. 2023;31(2):82-86. doi:10.54846/jshap/1313
BibTeX
@article{Sargeant2023,
author = {Sargeant, Jan and O'Connor, Annette and O'Sullivan, Terri and Ramirez, Alejandro},
title = {Maximizing value and minimizing waste in clinical trial research in swine: Design features to minimize bias},
journal = {Journal of Swine Health and Production},
year = {2023},
volume = {31},
number = {2},
pages = {82--86},
doi = {10.54846/jshap/1313}
}
EUVIMED